{"mainPropery":{"diseaseId":4768,"diseaseName":"Schwannomatosis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/4768/schwannomatosis","synonyms":["Neurilemmomatosis congenital cutaneous","Congenital cutaneous neurilemmomatosis","Neurofibromatosis type 3","NF3"],"synonyms-with-source":[{"name":"Neurilemmomatosis congenital cutaneous"},{"name":"Congenital cutaneous neurilemmomatosis"},{"name":"Neurofibromatosis type 3","source":"OrphaData.Org"},{"name":"NF3","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"OMIM","identifierId":"162091"},{"identifierType":"ORPHANET","identifierId":"93921"},{"identifierType":"UMLS","identifierId":"C1335929"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"},{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":15,"resourceName":"Nerve Tumours UK","abbreviation":"","address1":"1st Floor  ","address2":"44 Coombe Lane","address3":"","address4":"","address5":"","city":" London","state":"","zip":"SW20 0LA","country":"United Kingdom","phone":"44(0)208 439 1234","tty":"","tollFree":"07939 046 030 (Helpline)","fax":"","email":"info@nervetumours.org.uk","url":"https://nervetumours.org.uk","freeText":""},{"resourceID":16,"resourceName":"Children's Tumor Foundation","abbreviation":"CTF","address1":"120 Wall Street, 16th floor","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10005-3904","country":"United States","phone":"+1-212-344-6633","tty":"","tollFree":"1-800-323-7938","fax":"+1-212-747-0004","email":"info@ctf.org","url":"https://www.ctf.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/162091' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=Schwannomatosis%5Btitle%5D%20AND%20hasabstract%5Btext%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Schwannomatosis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='https://ghr.nlm.nih.gov/condition/schwannomatosis' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Schwannomatosis. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":752,"resourceId":1437,"resourceName":"Schwannomatosis - Children's Tumor Foundation","descriptionText":"The <a href='http://www.ctf.org/Learn-About-NF/Schwannomatosis.html' target='_blank'>Children's Tumor Foundation</a> provides information about schwannomatosis. Click on the above link to access this information.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C1335929' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/neurofibromatosis.html' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='https://www.ninds.nih.gov/Disorders/All-Disorders/Neurofibromatosis-Information-Page' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=93921' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1542,"resourceId":2170,"resourceName":"RePORTER","descriptionText":"The <a href='http://projectreporter.nih.gov/reporter.cfm' target='_blank'>Research Portfolio Online Reporting Tool (RePORT)</a> provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the \"Text Search\" box.  Then click \"Submit Query\".","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:3204' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Schwannomatosis. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Schwannomatosis:<br />\r\n<a href='https://nfregistry.patientcrossroads.org/' target='_blank'>NF Registry</a><br /><a href='https://sid2011.squarespace.com/' target='_blank'>International Schwannomatosis Database</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":3018,"questionText":"What is schwannomatosis?","answerText":"<strong>Schwannomatosis</strong> is a rare form of <a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10420/Neurofibromatosis.aspx\" target=\"_blank\">neurofibromatosis</a> that is primarily characterized by multiple schwannomas (<a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?CdrID=45614\" target=\"_blank\">benign</a> tumors of the nervous system) in the absence of bilateral (affecting both sides) <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000778.htm\" target=\"_blank\">vestibular schwannomas</a>. Signs and symptoms of the condition vary based on the size, location and number of schwannomas but may include pain; numbness; tingling; and/or weakness in the fingers and toes. Inherited forms of the disorder account for only 15 percent of all cases. In some of these families, schwannomatosis is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <em><a href=\"http://ghr.nlm.nih.gov/gene/SMARCB1\" target=\"_blank\">SMARCB1</a></em> or <em><a href=\"http://ghr.nlm.nih.gov/gene/LZTR1\" target=\"_blank\">LZTR1</a></em> genes; in other cases, the exact underlying cause is unknown. When inherited, the condition is passed down in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner with highly <a href=\"http://ghr.nlm.nih.gov/handbook/inheritance/penetranceexpressivity\" target=\"_blank\">variable expressivity</a> and <a href=\"http://ghr.nlm.nih.gov/handbook/inheritance/penetranceexpressivity\" target=\"_blank\">reduced penetrance</a>. Treatment is based on the signs and symptoms present in each person but may include medications and/or surgery.[9389][9390]","dateModified":"2015-07-26T00:00:00"},"basicQuestions":[{"questionId":9172,"questionText":"What are the signs and symptoms of schwannomatosis?","answerText":"Signs and symptoms of the schwannomatosis often develop during adulthood between ages 25 and 30. Affected people generally have multiple schwannomas, which are <a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?CdrID=45614\" target=\"_blank\">benign</a> tumors of the nervous system. In schwannomatosis, these tumors can grow along any nerve in the body, although they are less common on the vestibular nerve (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000778.htm\" target=\"_blank\">vestibular schwannomas</a>, also known as acoustic neuromas). People with vestibular schwannomas, especially those with tumors affecting the vestibular nerve on both sides of the head (bilateral), may have <a href=\"https://rarediseases.info.nih.gov/gard/7193/neurofibromatosis-type-2/resources/1\" target=\"_blank\">neurofibromatosis type 2</a> instead.[9389][9390] <br />\r\n<br />\r\nThe signs and symptoms associated with schwannomatosis vary based on the size and location of the schwannomas. The most common symptom is <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002312.htm\" target=\"_blank\">chronic</a> pain, which can develop as a growing schwannoma presses on nerves or surrounding tissues. Some people may develop a mass if the schwannomas is located just beneath the skin. Others can experience neurological symptoms such as numbness; tingling; and/or weakness in the fingers and toes.[9389][9390]<br />\r\n<br />","dateModified":"2015-07-26T15:02:00","resourceClassificationName":"Symptoms","references":[{"referenceId":9389,"authors":"","articleTitle":"Neurofibromatosis Fact Sheet","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke","date":"February 2015","volume":"","pages":"","url":"http://www.ninds.nih.gov/disorders/neurofibromatosis/detail_neurofibromatosis.htm#279853162","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9390,"authors":"Kaleb Yohay, MD; Amanda Bergner, MS, CGC","articleTitle":"Schwannomatosis","bookWebsiteJournalTitle":"UpToDate","date":"January 2015","volume":"","pages":"","url":"","dateAccessed":"2015-07-26T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9173,"questionText":"What causes schwannomatosis?","answerText":"Some cases of schwannomatosis are caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <em><a href=\"http://ghr.nlm.nih.gov/gene/SMARCB1\" target=\"_blank\">SMARCB1</a></em> or <em><a href=\"http://ghr.nlm.nih.gov/gene/LZTR1\" target=\"_blank\">LZTR1</a></em> genes.[9390] <em>SMARCB1</em> and <em>LZTR1</em> are <a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=46657\" target=\"_blank\">tumor suppressor genes</a>, which means that they encode a protein that stops cells from growing and dividing too rapidly or in an uncontrolled way. Mutations in these genes result in abnormal proteins that are unable to carry out their normal roles. This contributes to the development of the many different types of tumors found in schwannomatosis.<br />\r\n<br />\r\nWhen schwannomatosis is caused by a mutation in <em>SMARCB1</em> or <em>LZTR1</em>, the affected person is typically born with one mutated copy of the gene in each cell and is, therefore, <a href=\"http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/predisposition\" target=\"_blank\">genetically predisposed</a> to develop the tumors associated with the condition. For a tumor to form, two copies of the gene must be altered. The mutation in the second copy of the gene is considered a <a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=46586\" target=\"_blank\">somatic mutation </a>because it occurs during a person's lifetime and is not inherited.<br />\r\n<br />\r\nIn affected people without a mutation in <em>SMARCB1</em>&nbsp;or <em>LZTR1</em>, the underlying cause of the condition is unknown.","dateModified":"2015-07-26T15:26:00","resourceClassificationName":"Cause","references":[{"referenceId":9390,"authors":"Kaleb Yohay, MD; Amanda Bergner, MS, CGC","articleTitle":"Schwannomatosis","bookWebsiteJournalTitle":"UpToDate","date":"January 2015","volume":"","pages":"","url":"","dateAccessed":"2015-07-26T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9174,"questionText":"Is schwannomatosis inherited?","answerText":"Approximately 15% percent of all schwannomatosis cases are thought to be inherited.[9389] In these cases, the condition is thought to be inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner with highly <a href=\"http://ghr.nlm.nih.gov/handbook/inheritance/penetranceexpressivity\" target=\"_blank\">variable expressivity</a> and <a href=\"http://ghr.nlm.nih.gov/handbook/inheritance/penetranceexpressivity\" target=\"_blank\">reduced penetrance</a>.[9354] This means that a person only needs a change (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>) in one copy of the responsible <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a> in each cell to have a <a href=\"http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/predisposition\" target=\"_blank\">genetic predisposition</a> to the tumors associated with schwannomatosis. In some cases, an affected person inherits the mutation from an affected parent. Other cases may result from new (<a href=\"http://www.ghr.nlm.nih.gov/glossary=denovomutation\" target=\"_blank\">de novo</a>) mutations in the gene. These cases occur in people with no history of the disorder in their family. People with an inherited form of schwannomatosis have a 50% chance with each pregnancy of passing the condition on to the next generation.","dateModified":"2015-07-26T15:51:00","resourceClassificationName":"Inheritance","references":[{"referenceId":9354,"authors":"Evans DG","articleTitle":"Neurofibromatosis 2","bookWebsiteJournalTitle":"GeneReviews","date":"Updated March 15, 2018","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1201/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9389,"authors":"","articleTitle":"Neurofibromatosis Fact Sheet","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke","date":"February 2015","volume":"","pages":"","url":"http://www.ninds.nih.gov/disorders/neurofibromatosis/detail_neurofibromatosis.htm#279853162","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9175,"questionText":"How is schwannomatosis diagnosed?","answerText":"A diagnosis of schwannomatosis is often suspected based on the presence of characteristic <a href=\"https://rarediseases.info.nih.gov/gard/4768/schwannomatosis/resources/9\" target=\"_blank\">signs and symptoms</a>, especially if there are other family members with the condition. Additional testing can then be ordered to further support the diagnosis and rule out other conditions with similar features (namely, <a href=\"https://rarediseases.info.nih.gov/gard/7193/neurofibromatosis-type-2/resources/1\" target=\"_blank\">neurofibromatosis type 2</a>). This may include:[9390]\r\n<ul>\r\n    <li><a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?CdrID=44702\" target=\"_blank\">Tumor pathology</a> confirming that the growths are, in fact, schwannomas </li>\r\n    <li>Imaging studies, such as an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003335.htm\" target=\"_blank\">MRI</a> examining the vestibular nerve. It is important to rule out the presence of bilateral (affecting both sides) <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000778.htm\" target=\"_blank\">vestibular schwannomas</a> which would be suggestive of neurofibromatosis type 2 rather than schwannomatosis</li>\r\n    <li>Genetic testing for a change (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/SMARCB1\" target=\"_blank\"><em>SMARCB1</em></a> or <em><a href=\"http://ghr.nlm.nih.gov/gene/LZTR1\" target=\"_blank\">LZTR1</a></em> genes. Unfortunately, genetic testing is not informative in all people affected by schwannomatosis.</li>\r\n</ul>","dateModified":"2015-07-26T16:16:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":9390,"authors":"Kaleb Yohay, MD; Amanda Bergner, MS, CGC","articleTitle":"Schwannomatosis","bookWebsiteJournalTitle":"UpToDate","date":"January 2015","volume":"","pages":"","url":"","dateAccessed":"2015-07-26T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7383,"questionText":"How might schwannomatosis be treated?","answerText":"Treatment for schwannomatosis is based on the signs and symptoms present in each person. For example, pain is one of the most common symptoms of the condition. Treatment with medications such as <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a694007.html\" class=\"drug drug_general\" target=\"_blank\">gabapentin</a> or <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a605045.html\" target=\"_blank\">pregabalin</a> and the use of short-acting opioids and/or <a href=\"http://www.rheumatology.org/Practice/Clinical/Patients/Medications/NSAIDs__Nonsteroidal_Anti-inflammatory_Drugs/\" target=\"_blank\">nonsteroidal anti-inflammatories</a> for pain can be successful for many patients. If pain cannot be managed with other means or if the schwannomas are causing other symptoms, they can be surgically removed. However this treatment is often used as a last resort because surgery may put patients at risk of further neurologic problems.[9390]","dateModified":"2015-07-26T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":9390,"authors":"Kaleb Yohay, MD; Amanda Bergner, MS, CGC","articleTitle":"Schwannomatosis","bookWebsiteJournalTitle":"UpToDate","date":"January 2015","volume":"","pages":"","url":"","dateAccessed":"2015-07-26T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[{"referenceId":7275,"authors":"Yohay K & Bergner A.","articleTitle":"Schwannomatosis","bookWebsiteJournalTitle":"UpToDate","date":"2015","volume":"","pages":"","url":"http://www.uptodate.com/contents/schwannomatosis","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[{"relatedDiseaseId":10420,"relatedDiseaseName":"Neurofibromatosis","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":44180,"abbreviatedInquiry":"I have a segmental neuromatosis/schwannomatosis. The last 10 years the pain has been constant and gradually becoming worse. The last six moths have been dreadful. \r\nI would like to know what treatments work for others with the same condition. I have read some research work, but it is never anything like what I have got. I believe that surgery can be done? How successful is this? What medication works the best?\r\n","caseQuestions":[{"questionId":7383,"questionText":"How might schwannomatosis be treated?","answerText":"Treatment for schwannomatosis is based on the signs and symptoms present in each person. For example, pain is one of the most common symptoms of the condition. Treatment with medications such as <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a694007.html\" class=\"drug drug_general\" target=\"_blank\">gabapentin</a> or <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a605045.html\" target=\"_blank\">pregabalin</a> and the use of short-acting opioids and/or <a href=\"http://www.rheumatology.org/Practice/Clinical/Patients/Medications/NSAIDs__Nonsteroidal_Anti-inflammatory_Drugs/\" target=\"_blank\">nonsteroidal anti-inflammatories</a> for pain can be successful for many patients. If pain cannot be managed with other means or if the schwannomas are causing other symptoms, they can be surgically removed. However this treatment is often used as a last resort because surgery may put patients at risk of further neurologic problems.[9390]","dateModified":"2015-07-26T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":9390,"authors":"Kaleb Yohay, MD; Amanda Bergner, MS, CGC","articleTitle":"Schwannomatosis","bookWebsiteJournalTitle":"UpToDate","date":"January 2015","volume":"","pages":"","url":"","dateAccessed":"2015-07-26T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":10274,"phenoTypeName":"Abnormality of the skin","percentRanges":"-"},{"phenoTypeId":10253,"phenoTypeName":"Abnormality of the vertebral column","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":7386,"phenoTypeName":"Incomplete penetrance","percentRanges":"-"},{"phenoTypeId":7948,"phenoTypeName":"Meningioma","percentRanges":"-"},{"phenoTypeId":11450,"phenoTypeName":"Schwannoma","percentRanges":"-"},{"phenoTypeId":8123,"phenoTypeName":"Somatic mutation","percentRanges":"-"},{"phenoTypeId":13165,"phenoTypeName":"Spinal cord tumor","percentRanges":"-"},{"phenoTypeId":7381,"phenoTypeName":"Variable expressivity","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Schwannomatosis"}